U.S. Government Buys More Doses of Lilly Antibody Therapy
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. government has purchased 650,000 additional doses of the company's COVID-19 antibody therapy bamlanivimab. Lilly says the government is p... Read More
